Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Recruitment status now shows as closed ('No longer looking for participants'). The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and a new revision tag (Revision: v3.6.0) to reflect an update.
    Difference
    0.4%
    Check dated 2026-06-12T14:31:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page version was updated from v3.5.4 to v3.5.5, indicating a small maintenance update to the study record. The change does not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-05T10:31:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The Study Protocol and Statistical Analysis Plan PDF revision label changed from v3.5.3 to v3.5.4, signaling an updated document version. The page's core study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-05-15T03:15:09.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.2 to v3.5.3, indicating a new published version of the content. No substantive content changes are indicated by this update.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:35.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision number updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:19:30.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    - Added the term 'Squamous cell carcinoma of the head and neck' to the study's conditions / MeSH terms to reflect the applicable disease category.
    Difference
    0.1%
    Check dated 2026-04-01T22:35:18.000Z thumbnail image

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.